Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/17 → 2/13/18 |
A Two-Part, Multi-Center, Prospective, Phase 2/3 Clinical Study to Evaluate the Safety and Efficacy of GLASSIA as an Add-On Biopharmacotherapy to Conventional Steroid Treatment in Subjects with Acute Graft-Versus-Host Disease
- Hildebrandt, Gerhard (PI)